Patients with skin disorders are considered at a higher risk of depression and anxiety than the background population. Patients with hidradenitis suppurativa (HS) may be particularly affected.
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INTRODUCTION
Hidradenitis Suppurativa (HS) is a chronic, inflammatory skin disease. The estimated prevalence of HS is 0.1-4 % worldwide , Jemec et al., 1996 , Revuz et al., 2008 , Vinding et al., 2014 . The primary lesions are inflammatory nodules that may develop into abscesses and sinus tracts with subsequent scarring, affecting flexural sites such as the axillae and groins on a recurrent basis (Jemec, 2012 , Zouboulis et al., 2015 . Lesions of HS are typically described by patients as painful boils which, along with associated pus and odor, are associated with significant stigma, which negatively influences the health related quality of life (HRQoL) of patients through a range of psychosocial mechanisms (Deckers and Kimball, 2016 , Kouris et al., 2016 , Matusiak et al., 2010 , Tugnoli et al., 2016 .
The disease has several, clinically significant co-morbidities in addition to the pain and suppuration , Shlyankevich et al., 2014 , Vazquez et al., 2013 and although dermatology patients generally have an increased risk of phychiatric disease (Dalgard et al., 2015) , there are indications that HS patients may be particularly affected. A review on the handicap of HS (Deckers and Kimball, 2016) identified three studies that used questionnaires to determine the prevalence of depression in HS (Kurek et al., 2013 , Matusiak et al., 2010 , Onderdijk et al., 2013 and one study that investigated the prevalence of depression in HS using the large Clalit database containing aggregate heath data on 4.4 million inhabitants of Israel (Shavit et al., 2015) . The three questionnaire studies (Kurek et al., 2013 , Matusiak et al., 2010 , Onderdijk et al., 2013 found a prevalence of depression between 9% and 39% in patients with HS, but unfortunately used three different questionnaires, making direct comparison impossible (Deckers and Kimball, 2016) . Shavit et al. found 5.9% of the 3207 included patients with HS to have a co-morbid diagnosis of depression with a significantly increased Odds Ratio (OR) (95% Confidence Interval (CI)) of 1.7
(1.4-2.1) for depression as a comorbidity to HS after adjusting for age and gender (Shavit et al., (Scheinfeld et al., 2016 ) and a smaller Finish study found a questionnaire based diagnosis of depression in 38.5% of 26 included HS patients (Kluger et al., 2017) . In summary, all previus studies on depression in HS have found that HS patients have an augmented risk of depression, but the prevalence of depression in HS has been subject to considerable between-study variations, depending on the applied methodology.
Only a few studies have investigated the association between HS and anxiety. The Clalit database study found a co-morbid diagnosis of anxiety in 3.9% of the 3207 included HS patients with a significantly increased OR (95% CI) of 1.7 (1.3-2.1) (Shavit et al., 2015) and a casecontrol study involving 94 HS patients and 94 healthy control found that HS patients presented with higher questionnaire based diagnosis of anxiety (6.41 ± 3.31 vs. 5.00 ± 1.59, p < 0.001) than the healthy controls (Kouris et al., 2016) .
No studies on the association between HS and complete suicide appears when you search the literature.
The current study aims to explore depression, anxiety and completed suicides in HS patients further using Danish national registries, expanding the analysis to include prescription patterns of antidepressants and anxiolytic drugs.
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RESULTS
The study included 7,732 diagnosed HS patients with a mean age (Standard Deviation, SD) of 45.8 (12. 2) years and a background population of 4,354,137 with a mean age (SD) of 48.7 (18.0) years.
At baseline, smoking, alcohol abuse and diabetes was more prevalent among HS patients compared with the general population, as was the prevalence of depression, anxiety, antidepressant-and anxiolytic drug use, respectively (Table 1) . (Table 3) . Eleven events of completed suicide were observed in the HS patient population with an incidence rate of 0.29/1,000 PY (95% CI 0.16-0.53). The corresponding number of completed suicides in the background population was 2,904 with an incidence rate of 0.14/1,000 PY (95% CI 0.13-0.14) ( 
DISCUSSION
Our most predominant finding was the significantly increased risk of completed suicide in the cohort of HS patients, which remained increased even after adjustment for confounding factors. The increased risk may not solely be explained by demographic and lifestyle factors and the result may be seen as as a very clear indicator of how profoundly HS can affect the patients` lives. Reports on completed suicide among dermatological patients are far fewer than reports on suicidal ideation or depression, and in general, limited data have been published on the risk of self-harm, suicide attempts and completed suicide in patients with other common inflammatory skin diseases such as psoriasis, acne and atopic dermatitis. A recent systematic review (Chi et al., 2017) which included five population-based cohort studies of considered high quality (Egeberg et al., 2016b , Kimball et al., 2012 , Kurd et al., 2010 , Singhal et al., 2014 , Wu et al., 2017 found no increase in the risk of completed suicide (risk ratio [RR] 1.13; 95% CI 0.87-1.46), suicide attempt (RR 1.25; 95% CI 0.89-1.75), or suicidality (RR 1.26; 95% CI 0.97-1.64) among people with psoriasis. Several studies have reported a high prevalence of suicidal ideation in patients with acne, but a review on suicide risk in skin disorders (Picardi et al., 2013) only reported on one study investigating the risk of completed suicide in patients with severe acne (Sundstrom et al., 2010) . Although the risk of completed suicide estimates were higher for patients with acne as compared with the general population in this study, the findings were nonsignificant. Similarly, an increased risk of suicidal ideation was reported in patients with atopic dermatitis (Dieris-Hirche J, 2009, Kimata, 2006 , Zachariae et al., 2004 , whereas the risk of completed suicide is not increased in patients with atopic dermatitis compared with the general population . These observations strongly M A N U S C R I P T
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In accordance with previous studies we found a higher prevalence of depression and anxiety in HS patients compared with the background population in our cross-sectional analysis at baseline.
Adjusted ORs for association between HS and psychiatric comorbidity at baseline showed significantly increased association with anxiety, hospitalization due to anxiety, antidepressant and anxiolytic drug use but no increased ORs for depression and hospitalization due to depression.
Shavit et al. did find a significantly increased OR of association between depression and HS, albeit that the estimates were only adjusted for age and gender (Shavit et al., 2015) . Using a similar approach to that of Shavit et al., we also found ORs for depression and hospitalization due to depression at baseline significantly increased. The loss of significance association in the fully adjusted analysis suggests that this increased risk can be explained by socioeconomic and lifestyle disparities among the two groups and may therefore be taken to reflect the socioeconomic associations of HS , Theut Riis et al., 2017 . However, causality cannot be inferred from cross-sectional studies and while the socioeconomic status can be an aggravating factor for depression, HS could also be the reason for the lower socioeconomic status. If this is the case, the socioeconomic status adjusted results might be too restrictive and the `true´rates will be closer to age and gender only adjusted results. In addition, our cohort study design did find a significantly increased risk of antidepressant drug use, even in fully adjusted estimates, albeit that the risk of first-time diagnosed depression or hospitalization due to depression was not significantly Our cross-sectional analysis at baseline found an increased risk of anxiety, hospitalization due to anxiety and anxiolytic drug use, whereas our cohort-study did not. It may be speculated, that since HS is a chronic or recurrent disease with a significant diagnostic delay (Saunte et al., 2015) , most patients who reach hospital care have a long history of HS and selection bias may therefore occur. Anxiety may be hypothesized to be an early phenomenon meaning that it has developed before the entry of patients into the cohort. Conversely, attrition may play a role since prevalent cases were excluded in the cohort study. Quality of care may also influence these results. The knowledge about the management of HS patients is rapidly increasing and was much less developed before 2008 and the lack of association in the cohort study may therefore reflect better standards of care.
Our study revealed both an increased risk of completed suicide and indicated an increased risk of depression and anxiety among patients with HS. However, no conclusion about causality and link between these diagnoses can be made based on our results, and it should be noted that suicide is a symptom of a multitude of (psychiatric) diseases, not just depression and anxiety.
Several important limitations apply to the interpretation of our results. Due to the observational design of our study, we cannot determine causality. Selection bias towards moderatesevere cases with an associated higher level of co-morbidities may play a role because of the hospital setting of selection of HS patient to the study. Misclassification may also play a role as the inclusion is based on correct ICD coding of cases. (Ingvarsson, 2017 It is also a limitation that the Danish population is homogenous and predominantly white, and extrapolation of results to patients of other ethnicities should be conducted with caution.
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On the other hand, the study also has several important strengths. These include the high accuracy of the nationwide registries as well as the available information on household income, which minimized bias associated with sex, age, socioeconomic status, smoking, alcohol abuse and healthcare consumption. In addition, the design that combined a cross-sectional study with a cohort study providing follow-up data and the large included number in the analyses add credibility to our findings.
In summary, we have found a significantly increased risk of completed suicide in HS patients independent of measured confounders. We have also found an increased risk of depression and anxiety among HS patients compared with the background population, but our further analysis indicated that this increased risk by large is explained by confounding factors. This does however not make the psychiatric comorbidities less important, and all in all the results emphasizes the inescapable importance of clinicians treating the HS patient with psychiatric comorbidities in mind.
Ideally, this includes a structured development of strategies to prevent or minimize psychological comorbidities as well as the implementation of specific routines for clinical management. Effective assessment and treatment of psychiatric comorbidities and suicidality in HS patients with skin diseases depends on a multidisciplinary approach with access to a psychiatrist if needed. The use of patient reported outcomes including questionnaires for depression, anxiety and suicidal ideation in order to detect early stages and intervene to lower risk of progression is also recommended.
MATERIAL AND METHODS
This study is one of a series of explorative epidemiological studies of HS all using a similar approach. Please see (Egeberg et al., 2016a , Egeberg et al., 2017 , Theut Riis et al., 2016 .
Data sources
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Page 10 of 20 Ethics committee approval is not required for registry studies in Denmark, in agreement with legal requirements the study was however approved by the Danish Data Protection Agency (ref. 2007 -58-0015, int. ref. GEH-2014 . The study was conducted in accordance with the Strengthening the Reporting of Observational Studies in Epidemiology recommendations (von Elm et al., 2007) . In Denmark, the universal health care system provides the opportunities to perform population-based cohort studies. In brief, all residents are assigned a unique and permanent civil registration number at birth or on immigration. This unique identifier allows unambiguous linkage among all population-based administrative and health registries in the country (Schmidt et al., 2014) . Tax 
Study population
The study population consisted of all Danish adults (≥18 years) alive and resident in Denmark on January 1st 2008 (i.e. date of study start for all individuals in the cohort). Subjects were followed until December 31st 2012, migration, death, or the occurrence of an endpoint, whichever occurred first. All patients with a recorded diagnosis of HS (ICD-8 705.91 and ICD-10 L73.2) in the Danish National Patient Register prior to study start were classified as having HS. Tax-reported household M A N U S C R I P T
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Outcomes
The endpoints were a primary diagnosis in the Danish National Patient Register of depression 296.29, 296.99, 298.09, 300.19, , anxiety (ICD-8 300.0, 300.2 and ICD-10 F40-41), hospitalization for depression or anxiety, a recorded completed suicide in the National Causes of Death Registry (ICD-10 X60-X84), respectively, as well as a claimed prescription for antidepressants (ATC N06A), or anxiolytic drugs (ATC N05B), respectively.
Statistical analysis
Summary statistics were presented as means with standard deviation (SD) for normally distributed variables, medians and interquartile range (IQR) for non-normally distributed continuous variables and frequencies for categorical variables. The baseline period prevalence was determined as the percentage of individuals with one of the pre-specified diagnoses, or claimed a prescription, as appropriate, within the past five years before study start. A cross-sectional design was applied on January 1 st 2008 using logistic regression models to assess the odds ratios (ORs) of a history of psychiatric morbidity within the past five years. Moreover, we performed a cohort study in which the entire cohort was followed from study start and until the first of either December 31st 2012, death, migration, or the occurrence of an endpoint. SAS statistical software version 9.4 (SAS Institute Inc. Cary, NC, USA) and STATA software version 13.0 (StataCorp, College Station, TX, USA) were used to summarize incidence rates per 1,000 person-years, and Cox regression models were performed to obtain HRs in the cohort study. For the cohort study, incidence was examined for M A N U S C R I P T
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Page 12 of 20 all individuals without a history of the condition prior to study start, i.e. analyses of first-time outcome. ORs and HRs were calculated as age-and sex-adjusted, and fully adjusted (in which age, sex, socioeconomic status, smoking, alcohol abuse, and healthcare consumption were considered).
Socioeconomic status was calculated based on the mean annual income during the 5-year period before study start, and standardized by age. Model assumptions including the proportional hazards assumption was tested and found to be valid. All statistical tests were conducted using a level of significance of 0.05, and results were reported with 95% CIs, where applicable. 
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